 Epstein-Barr Virus Infections
"Epstein-Barr Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).
| Descriptor ID |
D020031
|
| MeSH Number(s) |
C02.256.466.313 C02.928.313
|
| Concept/Terms |
Epstein-Barr Virus Infections- Epstein-Barr Virus Infections
- Epstein Barr Virus Infections
- EBV Infections
- Infections, Epstein-Barr Virus
- Human Herpesvirus 4 Infections
- Herpesvirus 4 Infections, Human
- Epstein-Barr Virus Infection
- Epstein Barr Virus Infection
- Infection, Epstein-Barr Virus
- Virus Infection, Epstein-Barr
- Virus Infections, Epstein-Barr
- Infections, EBV
- EBV Infection
- Infection, EBV
- Human Herpes Virus 4 Infections
|
Below are MeSH descriptors whose meaning is more general than "Epstein-Barr Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Epstein-Barr Virus Infections".
This graph shows the total number of publications written about "Epstein-Barr Virus Infections" by people in this website by year, and whether "Epstein-Barr Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2000 | 3 | 0 | 3 | | 2001 | 4 | 0 | 4 | | 2002 | 6 | 1 | 7 | | 2003 | 3 | 1 | 4 | | 2004 | 3 | 0 | 3 | | 2005 | 4 | 1 | 5 | | 2007 | 5 | 0 | 5 | | 2008 | 3 | 0 | 3 | | 2009 | 3 | 1 | 4 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 5 | 2 | 7 | | 2013 | 2 | 1 | 3 | | 2015 | 6 | 1 | 7 | | 2016 | 3 | 1 | 4 | | 2017 | 2 | 1 | 3 | | 2018 | 3 | 1 | 4 | | 2019 | 3 | 0 | 3 | | 2020 | 2 | 0 | 2 | | 2021 | 2 | 0 | 2 | | 2022 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Epstein-Barr Virus Infections" by people in Profiles.
-
Hu G, Hauk PJ, Zhang N, Elsegeiny W, Guardia CM, Kullas A, Crosby K, Deterding RR, Schedel M, Reynolds P, Abbott JK, Knight V, Pittaluga S, Raffeld M, Rosenzweig SD, Bonifacino JS, Uzel G, Williamson PR, Gelfand EW. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A. Autophagy. 2023 Feb; 19(2):678-691.
-
Mavri M, Kubale V, Depledge DP, Zuo J, Huang CA, Breuer J, Vrecl M, Jarvis MA, Jovicic EJ, Petan T, Ehlers B, Rosenkilde MM, Spiess K. Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality. Front Endocrinol (Lausanne). 2022; 13:862940.
-
Tyler KL. The enigmatic links between Epstein-Barr virus infection and multiple sclerosis. J Clin Invest. 2022 05 02; 132(9).
-
Ramos-Gonzalez G, Crum R, Allain A, Agur T, O'Melia L, Staffa S, Burchett SK, Siegele B, Weinberg O, Rodig NM, Fawaz R, Singh TP, Freiberger DA, Bae Kim H. Presentation and outcomes of post-transplant lymphoproliferative disorder at a single institution pediatric transplant center. Pediatr Transplant. 2022 08; 26(5):e14268.
-
Fechtner S, Berens H, Bemis E, Johnson RL, Guthridge CJ, Carlson NE, Demoruelle MK, Harley JB, Edison JD, Norris JA, Robinson WH, Deane KD, James JA, Holers VM. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles. Arthritis Rheumatol. 2022 04; 74(4):597-603.
-
Dávila Saldaña BJ, John T, Bonifant C, Buchbinder D, Chandra S, Chandrakasan S, Chang W, Chen L, Elfassy HL, Geerlinks AV, Giller RH, Goyal R, Hagin D, Islam S, Mallhi K, Miller HK, Owen W, Pacheco M, Patel NC, Querfeld C, Quigg T, Richard N, Schiff D, Shereck E, Stenger E, Jordan MB, Heslop HE, Bollard CM, Cohen JI. High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. Blood Adv. 2022 01 25; 6(2):452-459.
-
Sebastian P, Cherbuin N, Barcellos LF, Roalstad S, Casper C, Hart J, Aaen GS, Krupp L, Benson L, Gorman M, Candee M, Chitnis T, Goyal M, Greenberg B, Mar S, Rodriguez M, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Graves J, Waubant E, Lucas R. Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. Neurology. 2022 01 18; 98(3):e267-e278.
-
Silva O, Charu V, Ewalt MD, Metcalf RA, Zhao S, Castellanos EM, Orellana E, Natkunam Y, Luna-Fineman S. Classic Hodgkin lymphoma in Guatemalan children of age less than six years: analysis of immune regulatory pathways and the tumor microenvironment. Leuk Lymphoma. 2021 07; 62(7):1609-1618.
-
Wang Z, Kennedy PG, Dupree C, Wang M, Lee C, Pointon T, Langford TD, Graner MW, Yu X. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands. J Neuroimmune Pharmacol. 2021 09; 16(3):567-580.
-
Smith NA, Coleman CB, Gewurz BE, Rochford R. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells. J Virol. 2020 05 18; 94(11).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|